All Gilead Sciences Inc news

Yesterday Surprising monkey study could lead to 'functional' HIV cure - Daily Mail
Yesterday Gilead Sciences, Inc.'s $10 Billion Mistake - FOX Business
Yesterday Gilead Sciences, Inc.'s $10 Billion Mistake - FOX Business
Yesterday Surprising Monkey Study Could Lead to 'Functional' HIV Cure - Newsmax
Yesterday Switching course, Gilead markets HIV drug for prevention - FOX News
Yesterday Surprising monkey study could lead to 'functional' HIV cure - FOX News
Yesterday Surprising monkey study could lead to ‘functional’ HIV cure - Eye Witness News
Yesterday World Aids Day: Surprising monkey study could lead to 'functional' HIV cure - dna
Yesterday Surprising monkey study could lead to 'functional' HIV cure - Reuters
Yesterday US regulator approves Gilead sciences' HIV drug cocktail - asianage
Yesterday Surprising monkey study could lead to 'functional' HIV cure - Times of Malta
Yesterday Surprising monkey study could lead to 'functional' HIV cure - Decclan Chronicle
Yesterday World Aids Day: Switching course, Gilead markets HIV drug for prevention - dna
Yesterday Surprising monkey study could lead to 'functional' HIV cure - EuroNews
Yesterday Surprising monkey study could lead to 'functional' HIV cure - Channel NewsAsia
Yesterday Surprising monkey study could lead to 'functional' HIV cure - The Star
2 days ago Switching course, Gilead markets HIV drug for prevention - NBC News
16 days ago Gilead Sciences Announces Promotion of James R. Meyers to Executive Vice President, Worldwide Commercial Operations - Business Wire
16 days ago Gilead Announces Top-Line Results From Two Phase 3 Studies Evaluating Momelotinib for Patients With Myelofibrosis - Business Wire
17 days ago Gilead Sciences to Present at the Annual Piper Jaffray Healthcare Conference on Tuesday, November 29 - Business Wire
18 days ago Trump Win Doesn't Get Pharma Off the Hook on High Drug Prices - Newsmax
18 days ago Trump Win Doesn’t Get Pharma Off the Hook on High Drug Prices - Swissinfo
21 days ago Trump's victory affects different stocks in different ways. Here's a breakdown - Los Angeles Times
22 days ago U.S. Food and Drug Administration Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection - Business Wire
22 days ago Investigational treatment combination improves virologic control in SIV-infected monkeys - News-Medical-Net
23 days ago Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients - News-Medical-Net
23 days ago J&J vaccine plus Gilead immune booster shows promise as HIV fighter - EuroNews
24 days ago What The Charts Are Saying About Gilead Sciences Inc. (NASDAQ:GILD) - Stock Talk Daily
28 days ago Sweeping drug-pricing investigation pulls in Impax Laboratories ( IPXL) - Bizjournals
30 days ago Beaten-down biotechs pin hopes on drug licensing deal - Boston Globe
30 days ago How Big Pharma is gouging your drug plan - The Globe and Mail
A month ago Gilead sales of Hepatitis C drugs slump - Market Watch
A month ago Gilead Sciences Shares Slide After Revenue Beat, Earnings Miss - FOX Business
A month ago Gilead Sciences Shares Slide After Revenue Beat, Earnings Miss - FOX Business
A month ago Gilead Sciences shares slide after revenue beat, earnings miss - Market Watch

Create a custom search

News search supports Google type search formatting and the use of complex boolean. Wrap terms in double quotes for exact phrase matching. Click + to add multiple news search terms to this topic.